Management of HER2 alterations in non-small cell lung cancer – The past, present, and future
Article in Lung Cancer (September 2023)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
The role of Her-2 in penile squamous cell carcinoma progression and cisplatin chemoresistance and potential for antibody-drug conjugate-based therapy
Article in European Journal of Cancer (September 2023)
Antibody Drug Conjugates in Lung Cancer: State of the Current Therapeutic Landscape and Future Developments
Article in Clinical Lung Cancer (July 2021)